Your browser doesn't support javascript.
loading
Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
Landbloom, Ronald L; Mackle, Mary; Wu, Xiao; Kelly, Linda; Snow-Adami, Linda; McIntyre, Roger S; Mathews, Maju; Hundt, Carla.
Afiliação
  • Landbloom RL; Merck, Whitehouse Station, NJ, USA.
  • Mackle M; Merck, Whitehouse Station, NJ, USA.
  • Wu X; Forest Research Institute (now Actavis), Jersey City, NJ, USA.
  • Kelly L; Merck, Whitehouse Station, NJ, USA.
  • Snow-Adami L; Merck, Whitehouse Station, NJ, USA.
  • McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, ON, Canada.
  • Mathews M; Forest Research Institute (now Actavis), Jersey City, NJ, USA.
  • Hundt C; Forest Research Institute (now Actavis), Jersey City, NJ, USA. Electronic address: carlahundt@msn.com.
J Affect Disord ; 190: 103-110, 2016 Jan 15.
Article em En | MEDLINE | ID: mdl-26496015

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Compostos Heterocíclicos de 4 ou mais Anéis Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Compostos Heterocíclicos de 4 ou mais Anéis Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article